Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | PF562271 | 0.316 | 1.000 | uM | 72 | hr | 2 | 1741 | 82 | 0.4786 | 0.4655 | 0.0471 | 0.0405 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 867 | 41 | 0.6326 | 0.6038 | 0.0473 | 0.0460 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 2 | 21096 | 999 | 0.9631 | 1.0000 | 0.0474 | 0.0468 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 3 | 548 | 26 | 0.5126 | 0.6959 | 0.0474 | 0.0496 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 737 | 35 | 0.6894 | 0.6789 | 0.0475 | 0.0471 |
A-375 | Vemurafenib | Defactinib | 1.000 | 0.316 | uM | 72 | hr | 3 | 3044 | 145 | 0.1389 | 0.1394 | 0.0476 | 0.0554 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 1.000 | uM | 72 | hr | 2 | 2625 | 125 | 0.8154 | 0.7361 | 0.0476 | 0.0573 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 1 | 19613 | 936 | 1.0160 | 1.0000 | 0.0477 | 0.0485 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 2917 | 139 | 0.9061 | 0.7091 | 0.0477 | 0.0504 |
A-375 | Vemurafenib | I-BET | 0.100 | 1.000 | uM | 72 | hr | 3 | 3934 | 188 | 0.2747 | 0.3080 | 0.0478 | 0.0484 |
A-375 | Vemurafenib | JNK-IN-8 | 0.000 | 0.000 | uM | 72 | hr | 3 | 16730 | 807 | 1.0016 | 1.0000 | 0.0482 | 0.0476 |
MMAC-SF | Vemurafenib | Saracatinib | 0.000 | 0.316 | uM | 72 | hr | 3 | 1846 | 89 | 1.4019 | 1.3011 | 0.0482 | 0.0459 |
A-375 | Vemurafenib | Defactinib | 0.000 | 0.000 | uM | 72 | hr | 3 | 22342 | 1082 | 1.0188 | 1.0000 | 0.0484 | 0.0468 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 0.316 | uM | 72 | hr | 1 | 1158 | 56 | 1.0822 | 1.3028 | 0.0484 | 0.0415 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 2 | 3900 | 189 | 0.1943 | 0.1915 | 0.0485 | 0.0418 |
MZ7-mel | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 1 | 4472 | 217 | 1.3491 | 0.9268 | 0.0485 | 0.0478 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2740 | 133 | 0.8503 | 0.6154 | 0.0485 | 0.0443 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 1645 | 80 | 0.3147 | 0.3555 | 0.0486 | 0.0539 |
MMAC-SF | Vemurafenib | Dasatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 885 | 43 | 0.6449 | 0.7202 | 0.0486 | 0.0513 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1827 | 89 | 0.0910 | 0.1035 | 0.0487 | 0.0423 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 2 | 19375 | 946 | 1.0025 | 1.0000 | 0.0488 | 0.0485 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 1 | 818 | 40 | 0.7640 | 0.6789 | 0.0489 | 0.0471 |
MMAC-SF | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 2 | 757 | 37 | 0.7070 | 0.6959 | 0.0489 | 0.0496 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 3 | 18973 | 930 | 0.9815 | 1.0000 | 0.0490 | 0.0485 |
MZ7-mel | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1425 | 70 | 0.2725 | 0.3555 | 0.0491 | 0.0539 |